Cargando…
The combination of pre-neoadjuvant chemoradiotherapy inflammation biomarkers could be a prognostic marker for rectal cancer patients
The neutrophil-to-lymphocyte ratio (NLR) and lymphocyte-to-monocyte ratio (LMR) have a strong association with prognosis in patients with Stage II/III rectal cancer (RC). We attempted to explore a new system combining these two ratios, named the NLM score, and examine its prognostic value in Stage I...
Autores principales: | Zhang, Jing, Zhang, Lin, Gou, Yuanyuan, Diao, Panya, Hu, Yi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8917228/ https://www.ncbi.nlm.nih.gov/pubmed/35277532 http://dx.doi.org/10.1038/s41598-022-07726-y |
Ejemplares similares
-
Prognostic value of pretreatment systemic inflammatory markers in patients with locally advanced rectal cancer following neoadjuvant chemoradiotherapy
por: Zhang, Yiyi, et al.
Publicado: (2020) -
Predictive value of proteomic markers for advanced rectal cancer with neoadjuvant chemoradiotherapy
por: Wang, Hanyang, et al.
Publicado: (2022) -
Clinical and Prognostic Significance of Pathological and Inflammatory Markers in Mucinous Rectal Cancer Patients Receiving Neoadjuvant Chemoradiotherapy and Curative Surgery
por: Zhao, Jian, et al.
Publicado: (2017) -
Prognostic and staging value of tumor deposits in patients with rectal cancer after neoadjuvant chemoradiotherapy
por: Xu, Tianlei, et al.
Publicado: (2021) -
Neoadjuvant chemoradiotherapy determines the prognostic impact of anastomotic leakage in advanced rectal cancer
por: Oh, Bo Young, et al.
Publicado: (2022)